Physician profile
Keith A Meetze
NPI 1407927759
$1,014.04
in general payments reported to CMS, 2019-2025
16 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.78 · 2020: $48.63 · 2021: $115 · 2022: $61.45 · 2023: $125 · 2024: $272 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $323.78 | 2020-2025 | |
| Glaxosmithkline, LLC. | $220.29 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $140.07 | 2024-2025 | Dupixent |
| Stryker Corporation | $78.98 | 2019-2021 | |
| Acclarent, INC | $58.06 | 2019-2021 | |
| Smith+Nephew, INC. | $29.43 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $24.89 | 2025 | Neffy |
| Preceptis Medical, INC. | $21.19 | 2024 | Hummingbird Tympanostomy Tube System |
| Alk-Abello, INC | $19.52 | 2021 | |
| Olympus America INC. | $17.32 | 2019 | |
| Integra Lifesciences Corporation | $17.20 | 2022 | |
| Hikma Pharmaceuticals USA | $16.23 | 2023 | Ryaltris |
| Optinose US, INC. | $15.11 | 2019 | |
| Intersect Ent, INC. | $15.02 | 2019 | |
| Aerin Medical INC. | $14.09 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $2.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Meetze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.